Literature DB >> 7768632

p53 mutations in esophageal tumors from high-incidence areas of China.

Y Y Liang1, A Estève, G Martel-Planche, S Takahashi, S H Lu, R Montesano, M Hollstein.   

Abstract

Carcinomas of the upper digestive tract (squamous-cell carcinoma of the esophagus, adenocarcinoma of the cardia) from 24 patients residing in Linxian (China) and near-by high-incidence areas were analyzed for mutations in exons 5-8 of the p53 tumor-suppressor gene. Mutations were identified by polymerase chain reaction amplification and direct sequencing in 50% of the specimens. Eleven tumors harbored a single base-pair substitution leading to either an amino-acid substitution (8 tumors) or a chain-termination signal (3 tumors), and one tumor revealed a 15-bp deletion in exon 7 with a silent base substitution adjacent to the deletion site. Mutations occurred in all 4 exons examined, with a preponderance in exon 5. Of the 6 mutations identified among the 14 adenocarcinomas examined, 3 were G to T transversions, a mutation that has thus far been absent from reported mutations in Barrett's esophageal adenocarcinomas and dysplasias from patients residing in Europe and North America.

Entities:  

Mesh:

Year:  1995        PMID: 7768632     DOI: 10.1002/ijc.2910610505

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Authors:  J F Fléjou; V Gratio; F Muzeau; R Hamelin
Journal:  Mol Pathol       Date:  1999-10

Review 3.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

5.  p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China.

Authors:  Xiao-Mei Lu; Yue-Ming Zhang; Ren-Yong Lin; Xiao-Hui Liang; Ya-Lou Zhang; Xing Wang; Yan Zhang; Yan Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 6.  Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Authors:  Li-Dong Wang; Shu Zheng; Zuo-Yu Zheng; Alan G Casson
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.